Patent details

Basic Information

Publication number:

EP1688146

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP052506805

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Preparing aldesleukin for pharmaceutical use

French Title of Invention:

Préparation d' Aldesleukin pour l 'ulilisation pharmaceutique

German Title of Invention:

Aufbereitung von Aldesleukin zur pharmazeutischen Verwendung

SPC Number:

Dates

Filing date:

07/02/2005

Grant date:

18/07/2007

EP Publication Date:

18/07/2007

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

09/08/2006

EP B1 Publication Date:

18/07/2007

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

07/02/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/04/2023

 

 

Name:

Novartis Pharmaceuticals Corporation

Address:

One Health Plaza,, New Jersey 07936, East Hanover, United States (US)

History of Owners

From:

07/02/2005

To:

14/04/2023

Name:

Novartis Vaccines and Diagnostics, Inc.

Address:

4560 Horton Street, Emeryville, CA 94608, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

25/07/2007

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

Name:

Hora Maninder c/o Chiron Corporation

Address:

United States (US)

Classification

Main IPC Class:

A61K 38/20;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2023/06

Publication date:

05/05/2023

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20230000181A

Date Registered:

14/04/2023

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

Novartis Pharmaceuticals Corporation

Address:

One Health Plaza,, New Jersey 07936, East Hanover, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

29/01/2024

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
14/04/2023	Request For Change	4
19/04/2023	Outgoing Correspondence	1